Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
about
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.Replicative Homeostasis III: implications for antiviral therapy and mechanisms of response and non-responseSubtyping of hepatitis C virus isolates by a line probe assay using hybridizationInterferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.Recent advances in laboratory diagnosis of hepatitis C virus infection.Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infectionHepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases.Optimum predictors of therapeutic outcome in HCV patients in Pakistan.Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.Large-scale analysis of hepatitis C virus serological typing assay: effectiveness and limits.Review article: interferon and hepatitis C--factors predicting therapeutic outcome.Monitoring virological responses to interferon-ribavirin and interferon monotherapy of chronic hepatitis C re-treated due to relapse or non-response.Interferon alone or combined with ribavirin for acute prolonged infection with hepatitis C virus in chimpanzees.Safety of Sofosbuvir and Ribavirin Combination Therapy in a Patient Who Developed Anemia due to Ribavirin.The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
P2860
Q27469549-2A798DBC-F10A-4B43-8360-82F53BEF8C68Q27478215-20DC5812-D072-4A49-8138-C6389EBC51E4Q27485644-8AD32C80-D374-4245-BA3D-701726899FC4Q35270237-CAB39E67-F0B2-4F49-93D8-0F828A3A8A25Q35650062-196AF71D-3F18-4E21-8E26-BA9CBAA08706Q35825285-0573E551-66C9-40CB-AAAA-2BF240D47B07Q35938587-50418223-2AAF-4A95-9660-839800562701Q41143949-8CCDB6F4-21C1-4CBA-AE43-41AB6962213EQ42982311-8EB07D81-D2A2-4348-BD6C-149E3B36A741Q42987915-AE56ECBC-49EC-4218-A7EA-76D3E122D7A9Q42989240-F2B691A5-9519-4894-98B7-56C5F545F4C8Q43030170-0751E223-B7A2-42AF-9B00-A3BA47207922Q45369788-DA4577F8-FF9C-427A-8DBF-A10F0A549311Q47548449-85D155BF-BCDA-409C-989C-E8BA58749BC0Q53444006-A26A6848-89AB-4210-A37B-4BCA0D446273
P2860
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@en
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@nl
type
label
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@en
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@nl
prefLabel
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@en
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@nl
P2093
P2860
P1476
Factors useful in predicting the response to interferon therapy in chronic hepatitis C.
@en
P2093
Kobayashi M
Matsumoto T
P2860
P304
P356
10.1111/J.1440-1746.1993.TB01648.X
P577
1993-11-01T00:00:00Z